Send a comment on this item to LII:
Send a comment on this item to LII staff, who on weekdays will usually reply within 24 hours.
Adverse Event Reporting System (AERS)
AERS is a "database designed to support the FDA's post-marketing safety surveillance program for all approved drug and therapeutic biologic products. The FDA uses AERS to monitor for new adverse events and medication errors that might occur with these marketed products." The site features quarterly reports, a table showing potential signals of serious risks identified by AERS, and related material. From the Food and Drug Administration (FDA).
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm
Asterisk
*
indicates required field.
Your Name
Your Email Address
*
We will not sell or provide your email address to anyone else.
Comment
*
Enter the verification code as it is shown in the box below. This helps prevent automated submissions.
*
